New Preterm Birth Drug Approved
February 22, 2011
The Food and Drug Administration has approved an injectable drug to reduce the risk for preterm birth in at-risk women.
Topics:
Health Medical Pharma, Social Issues, Preterm birth, Childbirth, Medicine, Food and Drug Administration, Tocolytic, 17-Hydroxyprogesterone caproate, Steroid hormones, Reproduction